Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Benzoate (DAOI) for Mild Alzheimer's Disease
NCT03752463Phase 2Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- May 2015
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium benzoate in Alzheimer's disease (AD), sponsored by Chang Gung Memorial Hospital. Started May 2015; status: completed.
02
Drugs
sodium benzoate
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03752463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03752463.